Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Breast cancer 9 5
Kaposi's sarcoma 3 1
Ovarian cancer 2 1
Ewing's sarcoma of bone 1 1
Hepatoblastoma 1 0
Multiple myeloma 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
1
Moderate
5
Mild
3
None
0

Commonly reported side effects and conditions associated with Doxorubicin

Side effect Patients
Fatigue 4
Nausea 4
Hair loss 3
Burning sensation in soles of feet 1
Constipation 1
Dilated cardiomyopathy 1

Show all 14 reported side effects

Why patients stopped taking Doxorubicin

Multiple reasons could be selected

Reason Patients
Course of treatment ended 11
Doctor's advice 4
Did not seem to work 2
Side effects too severe 2
See all 15 patients who've stopped taking Doxorubicin

Duration

Stopped taking Doxorubicin

Duration Patients
Less than 1 month 3
1 - 6 months 10
6 months - 1 year 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 9
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 5
A little hard to take 3
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 2
Not specified 6

What people switch to and from

Patients started taking Doxorubicin after stopping:

Treatment Patients
Vorinostat (Zolinza) 1
Last updated:
There are no evaluations for Doxorubicin.